Kristina Cossen
Pediatric Endocrinology · Atlanta, GANPI 1942576848
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Zealand Pharma A/s at 54.0% of the total. Reporting peaked in 2023 at $1,015 and has fallen 77.7% since, to $227 in 2025.
Across 9 payments — averaging $196.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zealand Pharma A/s$954
- Mannkind Corporation$350
- BETA Bionics, Inc.$197
- Sanofi-aventis U.S. LLC$194
- Abbott$33
- IBSA Pharma Inc.$21
- plus $17 from 1 others
Across 125 payments — averaging $2463.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mannkind Corporation$133K
- Zealand Pharma A/s$95K
- Eli Lilly$51K
- Abbott$30K
- IBSA Institut Biochimique SA$260
What the payments were for
- Speaking & faculty fees$623%
- Travel & lodging$92252%
- Food & beverage$78244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zealand Pharma A/s | 2 | $954 |
| Mannkind Corporation | 2 | $350 |
| BETA Bionics, Inc. | 1 | $197 |
| Sanofi-aventis U.S. LLC | 1 | $194 |
| Abbott | 1 | $33 |
| IBSA Pharma Inc. | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$590
- AFREZZA$288
How this compares
$1,765 in reported general payments places this provider in the 55th percentile of 30 pediatric endocrinology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methimazole | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Atlanta
- Quentin VanmeterAtlanta$215K
- Eric FelnerAtlanta$24K
- Daniel HsiaAtlanta$6K
- Stephen AndersonAtlanta$1K
- Andrew MuirAtlanta$1K
- Marjorie GolekohAtlanta$808
- Rajeev ThirunagariAtlanta$463
- Noreen IslamAtlanta$356
- Mark RappaportAtlanta$306
- Malinda WuAtlanta$243
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.